Meet The Aseptic Filling Workcell: Standardized Aseptic Filling Technologies For Clinical And Commercial Drug Products

Aseptic filling workcells are transforming drug product manufacturing by eliminating operator intervention and reducing contamination risks. These closed robotic systems integrate machine vision and gloveless isolator technology to deliver a fully automated, recipe-driven process that ensures sterility and repeatability across multiple dosage formats. With rapid implementation timelines—6–9 months for Microcell™ and 12–15 months for SA25—manufacturers can accelerate GMP production and bring therapies to patients faster. Designed for agility, these systems support multiproduct portfolios and high-value treatments, while offering precision up to 10 times greater than conventional pumps. Proven globally, workcells have achieved regulatory approvals across major markets and demonstrated exceptional reliability, including zero failures in 49 media fills.

Explore how these innovations optimize aseptic operations and enable scalable solutions for clinical and commercial needs.